Cadila Healthcare informs about disclosure

23 Sep 2021 Evaluate
Cadila Healthcare has informed that it enclosed disclosure in prescribed Form C under Regulation 7[2] of SEBI [Prohibition of Insider Trading] Regulations, 2015, received from Nitin Parekh, Chief Financial Officer of the Company with respect to sale of 10,000 Equity Shares of Re 1 each in the open market.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

896.60 3.15 (0.35%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×